CytomX Therapeutics Inc (FRA:6C1)
€ 2.942 +0.072 (+2.51%) Market Cap: 648.65 Mil Enterprise Value: 367.77 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 36/100

CytomX Therapeutics Inc (FRA:6C1) Transcripts

  • 1